Effects of Drinking Electrolyzed Alkaline-Reduced Water on Functional Dyspepsia: A Randomized, Double-Blind, Controlled Prospective Trial
Johny Bajgai, Mihyun Lee, Yeon-Gyu Jang, Ki-Bong Lee, Subham Sharma, Y. Jeong, H. Park, S. Goh, C. Kim, Hyun Il Kim, Kyu-Jae Lee · Processes · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In with FD, fD-QoL score decreased significantly more in the EARW group after intervention than in the PW group (p < 0.05). These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in with FD. FD-QoL score decreased significantly more in the EARW group after intervention than in the PW group (p < 0.05).
What the Researchers Studied
The researchers studied with FD. The study used a randomized human clinical trial.
What Effects Did Molecular Hydrogen Have?
FD-QoL score decreased significantly more in the EARW group after intervention than in the PW group (p < 0.05). The authors concluded that the authors' clinical study suggests that long-term drinking of EARW (pH 9.5) may improve FD-related symptoms and the quality of life of FD patients through home-based administration.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a randomized human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was with FD. The reported sample size was 8. The study used a randomized human clinical trial.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://www.mdpi.com/2227-9717/11/3/968/pdf.